Skip to main content

Hotels & Biotech

Every day, we sift through the filings to spot where the real conviction lies โ€“ cutting through the noise to highlight the most meaningful insider moves.

๐Ÿ“Œ Robinhood Markets $HOOD โ€” Meyer Malka purchased $20.18 Million via Form 4. 

The Ribbit Capital founder and one of Robinhoodโ€™s earliest backers continues to build his position in the brokerage platform. 

What's particularly notable is that Malka was buying just last week as well, suggesting this isn't a one-off transaction but part of a broader accumulation campaign.

๐Ÿ“Œ Pebblebrook Hotel Trust $PEB โ€” Chairman & CEO Jon E. Bortz purchased $678,600 via Form 4.
 
A meaningful founder-led buy from the lodging REIT's chairman and chief executive. Founder purchases often stand out because these executives typically have the longest-term perspective on the underlying business.

Hereโ€™s The Hot Corner, with data from June 9, 2026:

๐Ÿ“Œ Design Therapeutics $DSGN โ€” Point72 Asset Management increased its 13G stake from 4.41% to 5.10%.

The multi-strategy investment firm crossed the key 5% reporting threshold, establishing a meaningful position in the biotech as it continues carving out a deep base.

๐Ÿ“Œ Rep. Gil Cisneros โ€” disclosed purchases in Microsoft $MSFT ($50,000 - $100,000) and Revvity $RVTY ($15,000 - $50,000).